Lev’s Cinryze To Get FDA Blood Products Advisory Committee Review
This article was originally published in The Pink Sheet Daily
Executive Summary
Treatment for hereditary angioedema faces advisory committee scrutiny as prophylactic treatment, but not acute indication.